Price to Sales ratio Analysis of Heron Therapeuti - Deep Dive
Latest FY PS
Period Ending - Dec-23
Excellent PS
0.0036
Period Ending - Dec-22
Very Poor PS
3.24
Growth
-99.89 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
3.43
PS Analysis of Heron Therapeuti
P/S Ratio of Heron Therapeuti with value of 3.43 indicates that stock price is high compared to sales of the company and may be overvalued. |
PS Ratio of HRTX drastically fell by -99.89 % this year. |
PS Ratio with value of 3.61 was highest in Year Dec-21 in last Five Years. |
PS Ratio with value of 0.0036 was lowest in Year Dec-23 in last Five Years. |
Latest PS Ratio with value of 0.0036 is lower than Average PS of 2.38 in last five years. |
Other PS Related Info of HRTX that may interest you.
Heron Therapeuti Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
HRTX | 3.2 | 3.22 | 0.621 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
Poor Value Stock |
FY - Historical Price to Sales of Heron Therapeuti
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
PS | 0.0036 | 3.24 | 3.61 | 3.28 | 1.79 | 3.02 | 5.62 |
Change | -99.89 % | -10.48 % | 10.29 % | 82.79 % | -40.70 % | -46.21 % | -94.08 % |
FY Chart of Price to Sales of Heron Therapeuti
Note : All Data Generated at the End of Trading Hours (EOD Data)